PROJECTS
>>Ramp up of Product Development Efficiencies
>>Transformation through In-Licensing & Site Transfers
>>Out-License of New Molecular Entity by Biotech Footprint Late
>>Strengthening of Overseas Footprint
>>Divestment of Late Life Cycle Products
>>Commercializing a Reformulated Product
>>Business Development for Development Stage Enabling Technology
>>Restructuring Clinical Operations
>>Optimal Drug Development Path and Licensing Process
>>Post-Merger integration of Research and Development operations
Business Development for Development Stage Enabling Technology
Garphi worked with a North American biotechnology company to help them understand the potential value of a development-stage enabling technology. Garphi interviewed area-specific opinion leaders, identified relevant strengths and weaknesses of the technology and estimated the value to potential to licensing partners. This work helped define an appropriate range of deal terms based on the stage of the product and historical deals.
• Performed analysis of licensing terms of comparable technologies
• Created sample term sheet to aid in negotiations of licensing terms
• Supported business development activities in preparation for licensing discussions.
